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Abstract
Juvenile polyarteritis nodosa (PAN) is a rare, necrotizing vasculitis, primarily affecting small to medium-sized
muscular arteries. Cardiac involvement amongst patients with PAN is uncommon and reports of coronary artery
aneurysms in juvenile PAN are exceedingly rare. We describe a 16 year old girl who presented with fever, arthritis
and two giant coronary artery aneurysms, initially diagnosed as atypical Kawasaki disease and treated with IVIG and
methylprednisolone. Her persistent fevers, arthritis, myalgias were refractory to treatment, and onset of a vasculitic
rash suggested an alternative diagnosis. Based on angiographic abnormalities, polymyalgia, hypertension and skin
involvement, this patient met criteria for juvenile PAN. She was treated with six months of intravenous
cyclophosphamide and high dose corticosteroids for presumed PAN related coronary vasculitis. Maintenance
therapy was continued with azathioprine and the patient currently remains without evidence of active vasculitis.
She remains on anticoagulation for persistence of the aneurysms. This case illustrates a rare and unusual
presentation of giant coronary artery aneurysms in the setting of juvenile PAN.
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Background
Juvenile polyarteritis nodosa (PAN) is a rare, necrotizing
vasculitis, primarily affecting small to medium-sized
muscular arteries [1]. Recent classification criteria from
EULAR/PRES require histopathology of necrotizing vas-
culitis or angiographic abnormalities (aneurysm, steno-
sis, or occlusion of small-medium arteries), plus one of
five of the following: skin involvement, myalgia or mus-
cle tenderness, hypertension, peripheral neuropathy, or
renal involvement, for diagnosis [2]. Cardiac involve-
ment amongst patients with PAN is not common. Well
described cardiac manifestations in adults with PAN
include pericarditis, arrhythmia and valvular disease.
There are infrequent reports of coronary arteritis, steno-
sis [3], dissection [4], and occasionally aneurysms [5]
associated with PAN, however renal and gastrointestinal
aneurysms are more common [6,7]. There is a paucity
of literature regarding coronary artery manifestations in
juvenile PAN, with limited information on demo-
graphics, clinical characteristics, treatment, and
outcomes. Herein we describe a case of coronary artery
aneurysms in an adolescent with juvenile PAN.
Case Presentation
This is a report of a 16 year old girl from St. Croix, U.S.
Virgin Islands, who had been previously diagnosed with
juvenile idiopathic arthritis (JIA) at 5 years of age, based
on reports of fever, arthritis, and chronic uveitis. She
received no systemic immunosuppressant medication
and appeared to be in remission for several years. In
December 2009 she presented with three days of sharp,
substernal chest pain, two days of fever, and one day of
bilateral hip pain causing difficulty ambulating. Physical
exam revealed a tall, slender girl with mild nasal conges-
tion. On cardiac exam she had a regular rate and
rhythm, normal S1 and S2, and no appreciable murmur.
Examination of her extremities revealed tenderness over
her bilateral greater trochanters and bilateral knee effu-
sions. Initial laboratory testing demonstrated white
blood cell count of 5.7 k/μl, hemoglobin 11.4 g/dl,
hematocrit 35.5%, platelets 156 k/μl, erythrocyte sedi-
mentation rate 75 mm/hr, C-reactive protein 16.9 mg/
dL, and normal urinalysis, creatinine, and cardiac
enzymes. In addition, the patient had a negative
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(ASLO), anti-nuclear antibody (ANA); as well as nega-
tive anti-cardiolipin, anti-DNA, anti-smith, anti-RNP,
anti-SSA, anti-SSB, and anti-neutrophil cytoplasmic
antibodies. Ophthalmologic exam performed during
hospitalization revealed trace asymptomatic uveitis.
Due to the severity of her chest pain, an echocardio-
gram was performed, which revealed two giant coronary
artery aneurysms. The proximal aneurysm involved the
left main coronary artery and measured 9 mm. The sec-
ond aneurysm involved the left anterior descending
artery distally and measured 8.7 mm (Figure 1). She had
qualitatively normal biventricular systolic function.
Radiographic imaging using magnetic resonance angio-
graphy and doppler ultrasound revealed no other vascu-
lar abnormalities in the chest, abdomen, pelvis, renal
and carotid arteries. Due to a prolonged course of 8
days of fevers, the presence of the coronary aneurysms
and a concern for atypical Kawasaki disease (KD), the
patient was started on aspirin and received two courses
of IVIG. In addition, she was started on anticoagulation
with warfarin. She was additionally treated with 1 gram
of intravenous methylprednisolone due to evidence of
persistent inflammation andh e rf e v e rs u b s e q u e n t l y
resolved.
One week following a ten day hospitalization, the
patient developed recurrence of fevers, arthritis and ele-
vation of acute phase reactants. Due to concern for
active systemic vasculitis, she was given a subsequent
dose of 1 gram of intravenous methylprednisolone,
followed by high dose oral corticosteroids (prednisone
60 mg daily). Gallium scan was performed to evaluate
for sarcoidosis and revealed no evidence of abnormal
Gallium uptake. Despite high dose corticosteroids, the
patient continued to have persistent fevers, arthritis,
myalgias, and elevated acute phase reactants, and devel-
oped a new erythematous, palpable, non-blanching pur-
pura over bilateral lower extremities. Skin biopsy
demonstrated leukocytoclastic vasculitis. Two weeks
after her rash appeared, she additionally developed per-
sistent hypertension, requiring treatment with amlodi-
pine. This patient met criteria for juvenile PAN based
on angiographic abnormalities and myalgias. This diag-
nosis was further supported by her hypertension and
vasculitic rash. She was treated with six months of intra-
venous cyclophosphamide and high dose corticosteroids
for presumed PAN related coronary vasculitis.
During outpatient evaluation, the patient underwent a
cardiac catheterization to evaluate distal coronaries and
any additional changes that may not have been visua-
lized on echocardiography. On selective coronary angio-
graphy, the two aneurysms were confirmed with no
additional abnormalities identified (Figure 2). No inter-
vention was made during the catheterization. Addition-
ally, the patient had a single photon emission computed
tomography (SPECT) myocardial perfusion scan with a
Tc-99 m Sestamibi injection to assess for possible car-
diac ischemia which may present during exertion. Dur-
ing the test, she had no chest pain, and there were no
electrocardiogram changes suggestive of ischemia.
Figure 1 Aneurysms visualized by echocardiography. Echocardiographic parasternal short axis view reveals two fusiform aneurysms of the
left anterior descending coronary artery. The proximal aneurysm (A1) measures 8.7 mm, and the distal (A2) measures 9.0 mm. The aorta (Ao)
and main pulmonary artery (PA) are seen in cross section.
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sis, have shown no significant change in the size of the
coronary aneurysms nor have new aneurysms been
noted. Currently acute phase reactants have normalized
and the patient remains with no evidence of active vas-
culitis. She was started on azathioprine for maintenance
therapy and is slowly being tapered off of corticoster-
oids. She remains on anti-coagulation with warfarin and
aspirin.
Discussion
This case illustrates a rare and interesting cardiac mani-
festation of juvenile PAN. The presence of giant coron-
ary artery aneurysms led to initial suspicion and
treatment for atypical KD. The patient was refractory to
IVIG and corticosteroids, as evidenced by persistent vas-
culitic symptoms, suggesting alternate diagnoses. Based
on angiographic abnormalities, myalgias, hypertension
and skin involvement, this patient met criteria for juve-
nile PAN. It is unclear to the authors whether or not
this patient’sp r i o rd i a g n o s i so fJ I Aw a sa c c u r a t eo ri f
she may have had an underlying form of vasculitis from
the onset.
KD and PAN have overlap of symptomatology. Both
entities are vasculitides affecting small and medium ves-
sels in children [8]. Early in t h ec o u r s ee i t h e rd i s e a s e
can have non-specific signs and symptoms such as fever
or malaise. Common signs and symptoms include rash,
petechiae, conjunctivitis, arthritis, aneurysms, or abdom-
inal complaints, including pain, emesis, or diarrhea [9].
A number of children have been diagnosed with KD, to
later manifest as PAN [8-10]. Similarly, “infantile PAN”,
historically thought to be within the spectrum of PAN,
is now understood to be KD [11,12]. Given that
coronary artery aneurysms develop in 17% of untreated
KD, it is unsurprising that PAN is mistaken for KD [13].
Coronary aneurysms occur in diseases other than KD,
and clinicians should have a higher index of suspicion
for other pediatric vasculitides.
Children with PAN may have a wide variety of cardiac
manifestations. In a case series of 31 children with PAN,
five children demonstrated cardiac involvement includ-
ing pericarditis, arrhythmia, and cardiac failure. One
child died of cardiac failure and hypertension. These
patients were treated with corticosteroids with some
receiving a cytotoxic agent [14]. Changes on echocardio-
gram include mitral stenosis, mitral regurgitation, tricus-
pid regurgitation, mitral valve prolapse, and pericardial
thickening [15-17]. Rare case reports additionally
describe electrocardiographic changes, cardiomegaly,
myocarditis, myocardial fibrosis, endocarditis, coronary
arteritis, myocardial infarction, pericarditis, and hyper-
trophy [3,17,18]. Histopathology has demonstrated evi-
dence of cardiac involvement with coronary arteritis
found in 18/36 cases of necrotizing vasculitis on autopsy
[19].
Detailed accounts of coronary artery involvement in
juvenile PAN are even sparser. One case series from
Saudi Arabia of children aged 2-11.5 years describes one
child with heart failure and coronary artery aneurysms
on angiography. The age, clinical characteristics, treat-
ment, and outcome are not included [20]. One of the
largest multicenter surveys of juvenile polyarteritis
describes 63 patients with systemic PAN. One patient in
this group had a cardiac aneurysm, but no further
details are provided [7]. In another report, two patients,
ages 3 and 15, were found with coronary artery aneur-
ysms and a presumed diagnosis of KD. Both patients
Figures 2 A and B. Aneurysms revealed by angiography. Lateral and AP views of selective angiography into the left coronary artery which
reveals two aneurysms (arrows). The proximal aneurysm is of the left main coronary artery and the distal aneurysm is of the left anterior
descending artery.
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markers, but biopsy confirmation was not described
[10].
Treatment of juvenile PAN is primarily aimed at
decreasing systemic vascular inflammation. It has been
demonstrated that corticosteroid therapy has an essen-
tial role in the initial management, with second line
therapies including cyclophosphamide or azathioprine
[7,21]. Additional reports suggest successful outcomes
with methotrexate, mycophenolate mofetil, IVIG, inflixi-
mab, or rituximab, however these reports are largely
based on adult-data, case reports and retrospective
reviews [21]. Anti-coagulation with warfarin and aspirin
was used to prevent clot formation in our patient’sc o r -
onary artery aneurysms. Due to the paucity of informa-
tion on coronary artery aneurysms in PAN, treatment of
her aneurysms was extrapolated from experience with
KD and other systemic vasculitides. In KD, treatment
for persistent aneurysms is dependent on the size and
flow of the lesion. The treatment of giant aneurysms (≥8
mm) with sluggish flow may consist of systemic anticoa-
gulation in addition to anti-platelet therapy [22]. Those
patients who are asymptomatic with smaller residual
aneurysms are to be continued on aspirin and make
improvements in their lifestyle such as weight manage-
ment in obese patients. In patients with symptoms sug-
gestive of ischemia, however, other therapies must be
initiated and testing done to identify possible worsening
of their clinical status [23]. An invasive intervention
may be necessary in the symptomatic patient. In the
pediatric population, ‘infantile PAN’ or KD, associated
with coronary aneurysms has been described with recov-
ery and even regression of the aneurysms [24,25]. Out-
comes of coronary artery aneurysms in PAN identified
pre-mortem are not well described.
Conclusion
Herein we report a rare case of an adolescent with juve-
nile PAN and multiple giant coronary artery aneurysms.
Medical management with intravenous pulse cyclopho-
sphamide and high dose corticosteroids led to resolution
of all evidence of active vasculitis. Currently, our
patient’s giant coronary aneurysms remain asympto-
matic and she continues on maintenance therapy with
azathioprine, warfarin and aspirin.
Consent
Written informed consent was obtained from the
patient’s parent for publication of this case report and
any accompanying images.
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